New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
15:32 EDTREN, TWER, FST, CZR, GSAT, OPK, NUAN, TRAK, CIM, RAX, VTR, JOBS, MR, ICPTNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Ventas (VTR), consensus $1.09; Nuance Communications (NUAN), consensus 27c; Intercept Pharmaceuticals (ICPT), consensus (12c); Rackspace Hosting (RAX), consensus 16c; Opko Health (OPK), consensus (9c); Mindray Medical (MR), consensus 54c; Chimera Investment (CIM), consensus 9c; Globalstar (GSAT), one estimate (4c); 51job (JOBS), consensus 32c; Dealertrack Technologies (TRAK), consensus 373c; Caesars Entertainment (CZR), consensus ($1.19); Towerstream (TWER), consensus (10c); Resolute Energy (REN), consensus 1c; Forest Oil (FST), consensus (2c).
News For VTR;NUAN;ICPT;RAX;OPK;MR;CIM;GSAT;JOBS;TRAK;CZR;TWER;REN;FST From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 23, 2015
11:31 EDTCZROptions with increasing implied volatility
Subscribe for More Information
09:05 EDTRAXRackspace and Digital Realty launch green U.K. data center
Rackspace (RAX), along with data center and colocation provider Digital Realty Trust (DLR), unveiled its new UK data center based in Crawley, West Sussex. The new operation is the first data center in the UK to make use of 'indirect outside air' cooling technology on this scale, without mechanical cooling, which means the overhead energy required to operate the data center has been cut by almost 80%.
05:44 EDTICPTIntercept FLINT trial data shows OCA treatment increases fibrosis resolution
Subscribe for More Information
April 22, 2015
11:08 EDTCZROptions with increasing implied volatility
Options with increasing implied volatility: CZR FMSA PSEC CSX AEO CRM BBY SPLS HPQ DTV
08:16 EDTRAXSeveral companies to benefit from hybrid cloud growth, says Pacific Crest
Subscribe for More Information
07:16 EDTOPKOPKO Health score test shows positive prostate cancer risk identification result
Opko Health (OPK) announced the publication of a study showing that the four kallikrein panel of biomarkers utilized in the OPKO 4Kscore Test accurately identifies risk for aggressive prostate cancer prior to prostate biopsy. The Prostate Testing for Cancer and Treatment study is a prospective randomized controlled trial conducted in the U.K. for the purpose of evaluating the cost effectiveness of conventional treatments in PSA-detected, clinically localized prostate cancer. The study showed that the four kallikrein panel enhanced aggressive prostate cancer detection compared with PSA and age alone.
07:07 EDTICPTEuropean Association for the Study of the Liver to hold annual meeting
50th Annual Meeting of EASL will be held in Vienna, Austria on April 22-26.
April 21, 2015
11:13 EDTCZRCaesar's falls for a second session, levels to watch
The stock is down over 3% to $9.69 at time of writing. At that price next support is at $9.15. Resistance is at $10.07.
10:59 EDTOPKOPKO Health announces publication of ProtecT study
OPKO Health announced the online publication of a study entitled “Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study” in the Journal of the National Cancer Institute. The study shows that the four kallikrein panel of biomarkers utilized in the OPKO 4Kscore Test accurately identifies risk for aggressive prostate cancer prior to prostate biopsy. The Prostate Testing for Cancer and Treatment, or ProtecT, study is a prospective randomized controlled trial conducted in the United Kingdom for the purpose of evaluating the cost effectiveness of conventional treatments in PSA-detected, clinically localized prostate cancer. Of the 82,428 men recruited for the trial, a total of 6129 men with elevated PSA who underwent prostate biopsy and provided an adequate blood sample were tested for the four kallikreins and their 4Kscore result was determined. The study showed that the four kallikrein panel enhanced aggressive prostate cancer detection compared with PSA and age alone. The area under the curve for the 4K model was 0.820 while the PSA model was 0.738 for high-grade cancer.
April 20, 2015
17:04 EDTCZROn The Fly: Top stock stories for Monday
Stocks on Wall Street were higher for the day, beginning the session sharply higher and remaining in positive territory throughout. China’s central bank announced a reduction in bank reserve requirements in an effort to increase liquidity and spur economic growth within the country. Following the open, the market moved in a relatively narrow range as investors await the latest round of earnings reports for one of the season's heavier weeks. ECONOMIC EVENTS: In the U.S., the Chicago Fed National Activity Index came in at 0.42 versus expectations for positive 0.1. In Asia, the People's Bank of China lowered its reserve requirement ratio, by 1 percentage point, the lowest since the financial crisis. Despite this, the Shanghai Composite Index fell 1.6% because regulators had already begun curbing speculative trading on Friday. COMPANY NEWS: Morgan Stanley (MS) advanced 0.57%, or 21c, to $36.96 after reporting earnings prior to the market open. The bank beat on both EPS and revenue, and also raised its dividend to 15c from 10c. CEO James Gorman was pleased with the quarter and cited growth across the majority of the company's operations. MAJOR MOVERS: Among the notable gainers was Hasbro (HAS), which rose 12.55% to end the session at $74.16 after reporting EPS and revenue in excess of analyst expectations. During its earnings conference call, the company appeared confident on its 2015 offerings which include Disney (DIS) Princess and Frozen product lines. Also higher was Rovi (ROVI), gaining 8.64% to close the day at $19.11 after renewing its licensing and program guide agreement with Charter (CHTR). Among the noteworthy losers was Caesars Entertainment (CZR), tumbling 17.01% to $10 after failing to reach an agreement on its restructuring. Also lower were a number of medical companies involved in the development of CAR-T cancer therapies, including Kite Pharma (KITE), Juno Therapeutics (JUNO), blue bird bio (BLUE), and ZIOPHARM Oncology (ZIOP). The drop followed disappointing, small-scale studies presented during the annual meeting of the American Association for Cancer Research. INDEXES: The Dow rose 208.63, or 1.17%, to 18,034.93, the Nasdaq advanced 62.79, or 1.27%, to 4,994.6, and the S&P 500 gained 19.22, or 0.92%, to 2,100.4.
10:54 EDTCZRCaesar's and Ad Hoc committee fail to reach agreement on resructuring
Subscribe for More Information
08:25 EDTRAXData centers,connectivity firms should be owned into results, says Pacific Crest
Subscribe for More Information
07:22 EDTRENIndependent Petroleum Association of America to hold a conference
IPAA-OGIS New York is being held in New York on April 20-22.
April 17, 2015
10:07 EDTGSATHigh option volume stocks
Subscribe for More Information
10:00 EDTICPTOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:53 EDTICPTIntercept initiated with a Buy, $465 target at UBS
UBS analyst Matthew Roden started shares of Intercept Pharmaceuticals with a Buy rating and $465 price target. Roden sees a favorable risk/reward ahead of the approval and commercial launch of the company's obeticholic acid, known as OCA, in primary biliary cirrhosis. Roden also thinks OCA's opportunity in nonalcoholic steatohepatitis is being undervalued at current share levels. Shares of Intercept closed yesterday up $2.53 to $274.44.
April 15, 2015
17:41 EDTCZRCaesar's close to deal over anti-money laundering lapses, Reuters says
According to sources, The U.S. Treasury Department's anti-money laundering unit is close to issuing a civil penalty to Caesars Entertainment over anti-money laundering lapses discovered during a lengthy probe, Reuters reports. Reference Link
April 14, 2015
14:05 EDTCZRNJ Gaming reports March total Win $203.9M vs. $199.3M a year ago
Subscribe for More Information
April 13, 2015
08:24 EDTICPTDeutsche Bank pharmaceuticals analyst holds an analyst/industry conference call
Subscribe for More Information
06:07 EDTICPTIntercept announces several presentations evaluating OCA
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use